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abstraCt
Background: Staphylococcus aureus (S. aureus) is documented as an opportunistic 
pathogen in hiV/aids infection.  increasing prevalence of resistance by S. aureus 
to commonly prescribed antimicrobials pose a threat in its treatment, resulting to 
increased morbidity and mortality.  the importance of each pathogen in resistance of 
S. aureus to antimicrobials has not been established. 
objectives: to identify, characterised and determine bacteria associated with wound 
infection.  to determine the relationship between hiV and infectors of wounds and 
the correlation of co-infection in S. aureus and drug susceptibility. 
Design:  A cross-sectional study conducted for over five years from 2003-2007.  
Setting: Centre for infections and parasitic disease Control research, Kenya medical 
research institute Clinic.
Subject: outpatient who were 18 years and above presenting with topical wounds at 
CipdCr- busia; Kenya medical research institute (Kemri) clinic. 
results: A total of 175 isolates were obtained. One hundred and four (59.4%) were S. 
aureus, 28(16.0%) proteus spp, 25(14.3%) e. coli and 18(10.3) pseudomonas spp. 59(49.2%) 
wounds had one bacteria, 58(48.3%) had more than one and three (2.5%) had none. Out 
of the 70 HIV + patients, 38(54.3%) had one bacteria and 32(45.7%) had more than one 
bacteria. Out of the 50 HIV - patients, 21(42.0%) had one bacteria and 26(52.0%) had 
more than one bacteria.  resistances of S. aureus from co-infected (with more than 
one bacteria) wounds were higher than those S. aureus from singly infected wounds 
that is, MRSA in single infection and co-infections showed significance differences  
as follows: [P values = 0.045, odds =5.5 (1-29.2) for  S. aureus versus S. aureus and e. 
coli], [P values = 0.032, odds =9.0 (1.0-8.0); S. aureus versus S. aureus and proteus], [p 
values = 0.046, odds = 8.0 (0.88-72.1); S. aureus versus S. aureus and pseudomonas].  
Significant drug susceptibility difference between HIV+ and HIV- patients was shown 
by chloramphenicol with P =0.027, odds= 5.7(1.3-24.1). Thus HIV + patients are five 
fold likely to develop resistance to chloramphenicol as compared to hiV – patients.
conclusion: more antibiotic susceptibility studies need to be done to elucidate the 
pathogenic mechanisms of S. aureus that is isolated from co-infected wounds.
introduCtion
Staphylococcus aureus is one of the most significant 
human indigenous flora (1). In normal circumstances, 
it exists naturally as an innocuous organism. 
However, this organism has been documented as 
human opportunistic pathogen which may cause 
disease depending on whether it is ingested, inhaled 
to the lungs or breaks the skin and mucous membranes 
and enters underlying tissues; thus resulting into 
infections which may cause morbidity and mortality 
(2,3). In conditions of impaired body defense 
mechanism such as HIV infection, diabetes mellitus 
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and hyperalimentation (4,5), S. aureus become very 
virulent resulting in a broad spectrum of infections 
ranging from mild to life threatening impetigo, boils, 
septicaemia, meningitis and pneumonia(3,6,7,8). 
 It has been observed that there is increasing 
frequency in resistance of S. aureus to commonly 
prescribed antimicrobials world wide (7,9).  Initially, 
S. aureus was resistant to penicillin, but later to other 
antibiotics including penicillinase stable antibiotic 
(3,10).  In the uSA, MRSA prevalence which was 
15-20% in 1997 rose to 32% in 2001 to 2002 (15) and 
37% in 2007 Crum et al (13).   A review study on 
prevalence of Methicillin-Resistant Staphylococcus 
aureus (MRSA) in eight African hospitals between 
1996-1997, showed that, the prevalence of MRSA 
in Kenya was 21-30%(11). In the year 2001, a study 
at Kenyatta National Hospital- Kenya, MRSA 
prevalence had increased to 33% (Kariuki et al; 
unpublished data). This increasing resistance of 
S. aureus to commonly prescribed antimicrobials 
(4,5,8,14-16) presents a major threat and concern 
in its management and treatment
 In particular, Methicillin Resistant Staphylococcus 
aureus (MRSA) which was initially a nosocomial 
pathogen, has recently spread in the communities 
and emerged as an important frequent opportunistic 
pathogen causing skin and soft tissue infections in 
HIV/AIDS individuals (9). Therefore, there was a 
need to carry out this study to determine the effects 
of co-infections in the antibiotic resistance of S. 
aureus isolated from HIV positive individual and 
come up with an effective regimen of antibiotics 
in the management of S. aureus.  This is because, 
many patients present at CIPDCR - clinic with skin 
conditions.  Due to other logistics CIPDCR was 
preferred because there are no similar studies done 
in Western part of Kenya.
materials and methods 
The study population included patients who 
presented at the Centre for infectious and Parasitic 
Diseases Control Research (CIPDCR) - (KeMRI)-
Busia clinic.  Qualified Clinicians recruited patients 
who were 18 years and above showing signs and 
symptoms of HIV/AIDS and had wounds. Patients 
were referred to VCT by clinicians.  In the VCT, 
they were counselled and tested by trained VCT 
counsellors.  They were again referred back to 
the clinicians who referred them to the laboratory 
for further investigations.  In the laboratory, 
the wounds were cleaned using sterile saline. 
Specimens were collected using sterile swabs and 
placed into normal saline.  Thereafter, specimen 
were cultured on 5% sheep blood and MacConkey 
agars and incubated at 370c for 18-24 hours. 
Smears were also made from the original swabs 
for gram stain to provide relevant information on 
bacteria on the wounds.  Colonies that were small 
and lacto-fermenters on MacConkey or golden 
yellow and haemolytic on sheep blood agar were 
identified by standard microbiological techniques 
(22).  These included, gram stain reaction; bacteria 
cell arrangement, catalase and coagulase among 
others for identification of S. aureus.  Other isolates 
were also identified appropriately using standard 
microbiological procedures.  Sensitivity was done 
by the Kirby-Bauer disk diffusion technique using 
Muller hinton agar (17).  Drugs tested were Penicillin 
10 units, Ceftazidime 30µg, Ampicillin 10µg, 
Amikacin 30µg, Ciprofloxacin 5 µg, erythromycin 
15µg, Oxacillin 1µg, gentamicin 10µg, Ceftizoxime 
30µg, Chloramphenicol 30 µg and Cefuroxime 30µg 
from BBLtm Company.  Incubation was done at 370c 
for 18-24 hours. Zones of inhibition were measured 
and interpreted based on the National Committee for 
Clinical Laboratory Standards (NCCLS) guidelines 
(3,6,17). Staphylococcus aureus ATCC 25923 was used 
as a control.  Patients were referred back to the 
clinicians for management.
Detection of Methicillin resistance Staphylococcus 
Aureus (MrSA): Pure colonies of S.aureus from 
overnight cultures were inoculated onto Mueller 
Hinton agar containing 2% sodium chloride. 
Oxacillin disk was used to detect MRSA.  The plates 
were incubated at 350c for 24 hours.  Those isolates, 
which showed zone diameters of ≤ 10mm, were 
considered as MRSA.  Known MRSA and MSSA 
strains were used as controls. 
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results
table 1
   Spectrum and isolation rate of pathogenic organisms (isolates) from wounds. n=175
 Total HIV positive HIV negative
Isolate %  %  % 
S.aureus   104(59.4)        
 62(35.4)   
          42(24.0)
Proteus spp.  28(16.0)          14(8.0)         14(8.0)  
Escherichia coli  25(14.3)          15(8.4)     10(5.7) 
Pseudomonas spp 18(10.3)          11(6.3)       7(40)) 
         
S. aureus was the most common isolate, followed by Proteus spp, E. coli and Pseudomonas spp. in 
hiV +, E. coli was as common as Proteus spp. in hiV -, Proteus was more common than E. coli. 
Proteus was as prevalent in HIV + as in HIV -. S. aureus, E. coli and Pseudomonas spp. were more 
likely to be found in HIV + than in HIV.  
    
Table 2
Number of pus swabs and isolates from both single and co-infected wounds (n =120)
 HIV positive HIV negative
Total No. of patients/ 70 50       
Pus swabs processed     
singly infected wounds with:   
S. aureus   30 (43%) 16(32%)
Proteus spp.  4(6%) 3(6%)
Pseudomonas spp.  2(3%) 2(4%)
E. coli        2(3%)                       -
Co-infected wounds with: 
S. aureus and Escherichia coli 13(19%) 10(20%) 
S. aureus and Pseudomonas spp.         9(13%) 5(10%)
S. aureus and Proteus spp.  10(14%) 11(22%)
No growth obtained (0%)     3(6%) 
S. aureus was a constant pathogen in all co-infections. Some wounds of HIV – patients did not 
have E. coli as single infection.
Table 3
Susceptibility test of S. aureus based on resistance rate (%) n=104
Isolates  S. aureus alone    S. aureus and E. coli    S. aureus and Proteus      S. aureus and
 spp.  Pseudomonas spp
Column a  Column b  Column c  Column d  Column e
HIV status HIV+ HIV-  HIV+  HIV-  HIV+  HIV-  HIV+ HIV-
Antibiotics  n=30  n=16  n=13  n=10  n=10  n=11  n=9  n=5
Pencillin  17(57)  9(56)  10(79)  8(80)  7(70)  9(82)  7(78)  4(80)
Ciprofloxacin  6(20)  1(6)  7(54)  3(30)  4(40)  3(27)  4(44)  1(20)
erythromicin  18(60)  8(50)  9(69)  7(70)  7(70)  7(70) 6(67)  3(60)
Oxacillin  15(50)  7(44)  11(85)  7(70)  9(90)  9(82)  8(89)  2(40)
gentamicin  7(23)  3(19)  6(49)  4(40)  5(50)  5(46)  5(56)  1(20)
Ceftizoxime  12(40)  6(38)  7(54)  6(60)  6(60)  6(55)  5(56)  3(60)
Chloramp
-henicol 17(57)  3(19)  9(69)  3(30)  6(60)  3(27)  7(78)  2(40)
Cefuroxime  4(13)  2(13)  4(31)  2(30)  4(40)  4(36)  3(33)  1(20) 
Note: Only S. aureus were tested
generally, the  resistances of S. aureus to all these antibiotics tested were higher in co-infections 
than in single infections. Figure 1 below with p-values = < 0.05 as an example.
268 East african MEdical Journal August 2011 
figure 1
Showing resistance (%) of S. aureus to oxacillin
  
                    
There were statistical significance differences in MRSA between single infection and co-infections 
as follows: [P-values = 0.045, Odds=5.5 (1-29.2); S. aureus vursus S. aureus and E. coli], [P-values 
= 0.032, Odds=9.0 (1.0-8.0); S. aureus vursus S. aureus and Proteus], [P-values =0.046, Odds= 8.0 
(0.88-72.1); S. aureus vursus S. aureus and Pseudomonas].
          
Figure 2
Showing resistance (%) of S. aureus chloramhenicol
Resistance of S. aureus to chloramphenicol is showing statistical significant differences between HIV 
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disCussion
Infections caused by S. aureus are a common problem 
worldwide (7,9). The emergence of antibiotic 
resistance by this pathogen is perturbing. Both 
nosocomial and community acquired infections due 
to this pathogen has also been reported.  In this study, 
S. aureus was the most frequently isolated pathogen 
from pus swabs obtained from both HIV positive 
62(35.4%) and HIV negative 42(24.0%) (Table 1) and 
it was the most common pathogen in both single and 
co-infections (Table 2).  The fact that S. aureus exist 
naturally as harmless organisms, its colonisation 
of nasal cavities (18) and on healthy skin of human 
might have given it a greater opportunity as an 
opportunistic pathogen in HIV infected patients thus 
entering ruptured skin of these immunosuppressed 
individuals causing secondary infections. 
 This rate of isolation has been reported in many 
other studies (8,18-20) which did not specify isolation 
rate in relation to HIV status.  Other organisms 
(Proteus spp, E. coli, Pseudomonas sp,) were isolated 
in small numbers (4.0-8.4%) (Table1).  This isolation 
rate is different from Ohene’s and Thanni’s studies, 
where pseudomonas spp was the most frequent isolate, 
followed by S. aureus then proteus spp and E. coli the 
least (19).  Co-infections were observed in a total of 
32 (45.7%) of 70 HIV positive and 26 (52.0%) of 50 
HIV negative patients as follows; S. aureus and E 
coli 13(19%) HIV+ and 10(20%) HIV-, S. aureus and 
Pseudomonas spp 9(13%) HIV+ and 5(10%) HIV-, S. 
aureus and Proteus spp 10(14%) HIV+ and 11(22%) 
HIV- (Table 2).  Some wounds were infected with 
only one pathogen such as S. aureus; 30(43%) HIV 
+ and 16(32%) HIV-, Proteus; 4(6%) HIV+ and 3(6%) 
hiV-, Pseudomonas; 2(3%) HIV+ and 2(4%) HIV-, E. 
coli; 2(3%) HIV+ and 0(0%) HIV- (Table 2). There were 
no significance differences in isolation rate between 
HIV + and HIV- patients.
 S. aureus had multiple antimicrobial resistances 
in both groups (Table 3).  This seem to agree with 
the study done on the prevalence of MRSA in eight 
hospitals selected from various African countries 
as cited by Kesah  et al, where >60% of S. aureus 
were multi-resistant (14). Although the difference in 
MRSA between HIV + and HIV – patients was not 
significant, there was significant differences between 
S. aureus isolated from co-infected wounds (70-90%) 
and separately infected ones (44-50%) with [P-values 
= 0.045, odds =5.5 (1-29.2); S. aureus vursus S. aureus 
and E. coli], [P-values = 0.032, odds =9.0 (1.0-8.0); S. 
aureus vursus S. aureus and Proteus], [P-values =0.046, 
odds = 8.0 (0.88-72.1); S. aureus vursus S. aureus and 
Pseudomonas].  The odds ratios indicate that, S. aureus 
from co-infected wounds, are five to nine folds likely 
to become MRSA compared to S. aureus isolated 
individually regardless of patient’s HIV status (figure 
1).  There is no clear explanation to this observation 
in our study; however, gene mutation which is a 
common factor in S. aureus (22) could play a possible 
role. This point will need further elucidation in the 
future studies. These high MRSA in co-infection 
conditions is worrying and this indicates that, the 
isolates from such conditions could be resistant to 
all penicillin including penicillinase stable antibiotic 
and cephalosporins that are not widely used and 
expensive to the patients. 
  generally, many studies done on MRSA have 
shown a gradual increase with time (11, 12, 19).  in 
Kenya, MRSA was 21-30% (11) by the year 1996-1997. 
A study at Kenyatta National referral Hospital- Kenya 
showed MRSA prevalence of 33% (Kariuki et al; 
unpublished data) in 2001 and accordingly, our study 
has shown 56-57% and 70-82% from singly infected 
wounds and co-infected wounds respectively.  MRSA 
prevalence in uSA rose from 15-20% in 1997 to 28% 
in 1998 to 32% between 2001-2002 and 37% by 2007. 
Many of these studies however have been hospital 
base (4,5,11,12). Community based studies have 
shown an increase in frequency of MRSA isolated from 
clinical specimens than in hospital cases.  Malonza et 
al reported 59.2% MRSA prevalence from outpatients 
attending Kenyatta National referral Hospital. 
However, our results show almost a double increase 
by S. aureus isolated from co-infected wounds and 
almost same to those isolated from singly infected 
wounds.  This has been attributed to indiscriminate 
usage of antibiotics leading to selection of resistance 
strains (19).  MRSA are a frequent occurrence from 
specimens from pus and wounds (3,8) and this shows a 
characteristic that seem to agree with our findings. 
 Resistance of S. aureus from both singly infected 
and co-infected wounds to Chloramphenicol was 
higher in HIV positive (57-78%) than in HIV negative 
(19-40 %) (Table 3).  Chi-square test established 
that there is significant in distribution of resistance 
between HIV + and HIV – (P= 0.027) Odds = 5.7(1.3-
24.1) (figure 2).  The odds ratio reveals that HIV+ 
patients are five folds likely to develop resistance to 
chloramphenicol compared to HIV – patients.  The 
prescription of chloramphenicol drug due to frequent 
typhoid related symptoms in HIV infected persons 
in absence of laboratory confirmation may have 
contributed to high resistance of S. aureus from HIV/
AIDS positive individuals.  Resistance of S. aureus from 
co-infected wounds to Ciprofloxacin, erythromycin, 
gentamicin, ceftizoxime and cefuroxime was higher 
in HIV positive than in negative.  Chi-square test 
established that there is significant difference in the 
distribution of resistance of S. aureus to antibiotics 
in patients who were HIV positive and negative, 
P- values of <0.05 (Table 1).
 Resistance of S. aureus isolates to gentamycin, 
ciprofloxacin and cefuroxime was lower (<25%) in 
both groups compared to other antibiotics (penicillin, 
erythromycin, ceftizoxime) (Table 3).  This is opposed 
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to what has been observed for hospital-based isolates 
(9,23,24).  A slight increase of resistance (up to a 
maximum of 56%) of S. aureus to three antibiotics 
gentamicin, ciprofloxacin, cefuroxime is shown in co-
infections (Table 3).  The administration of gentamycin 
through intravenous and intramuscular injection (25), 
high cost of ciprofloxacin to many patients might have 
limited its indiscriminate use among both groups. 
The resistances of S. aureus to cephalosporins have 
also been reported in other studies (9,12,20).  In our 
study, the resistance of S. aureus to Cefuroxime is <15% 
(Table 3) in singly infected wounds and between 20-
40% in co-infected wounds (Table 3).  The resistance 
of S. aureus to Ceftizoxime is ≤40% (Table 3) in singly 
infected wounds and between 54-60% in co-infected 
wounds (table 3).  This shows that, with widespread 
use of these drugs, resistance may develop perversely, 
regardless of them being expensive and unavailable 
to many patients. 
 Resistances of S. aureus from co-infected 
wounds were higher than those of S. aureus from 
singly infected wounds (Table 3). This shows that, 
co-infections in wounds have an impact on the 
susceptibility of S. aureus to antibiotics hence pose 
threat to its treatment.  S. aureus in presence of other 
pathogenic organisms could have acquired genes 
which might have mutated and assisted them in 
resisting commonly prescribed antibiotics.  This is 
noted in the emergence of B-lactamase mediated 
resistance to antibiotics.  Ampicillin (the first 
penicillin) was developed primarily to treat E. coli, 
within a few years, strains of E. coli became resistant by 
producing plasmid mediated B-lactamase designated 
TeM.  After a short time S. aureus expressed a similar 
B-lactamase (22).  enterobacteriacea (E. coli, Proteus 
mirabilis and Klebsiella) have been found to exhibit a 
broad spectrum beta lactam resistance pattern (26).  
epidemiological study has shown E. coli passing on 
the genes responsible for antibiotic resistance to S. 
aureus (27).  In presence of other pathogenic organisms, 
especially in HIV/AIDS, S. aureus might have 
acquired already resistant genes.  A good example has 
been also described by bacteriophages in Staphylococci 
for decades.  This has been speculated that the high 
prevalence of B-lactamase production in Staphylococci 
has resulted from bacteriophage-mediated transfer 
of nonconjugative plasmids (28). 
 Administration of antibiotics to patients prior 
to laboratory testing might have had an impact on 
the growth of S. aureus.  eight HIV + and five HIV- 
patients whose wounds yielded Proteus, Pseudomonas 
and E. coli only had been treated with cloxacillin just 
a month prior to this study.  The invasion of S. aureus 
into eukaryotic cells where MRSA is phagocytised by 
human macrophages, thus complete restoration of 
susceptibility to cloxacillin is shown and the strain 
becomes indistinguishable from MSSA due to the acid 
PH prevailing in Phagolysosomes (29,30) might have 
contributed to its growth.  The three HIV- patients 
whose yielded nothing had been treated with at least 
three different antibiotics (cloxacillin, ampicillin and 
chloramphenicol) just three months prior to this study. 
These patients were between 50-70 years old.  thus 
this implies  that the older the person, the longer 
it takes for a wound to heal because the pH of the 
skin increases and lipid content decline inhibiting 
the permeability of nonlipophilic compounds, thus 
reducing the efficacy of some medications.
 More studies need to be done to elucidate 
the pathogenic mechanisms leading to resistance 
of S. aureus in co-infected wounds.  Both clinical 
and laboratory diagnosis should be employed in 
the management of S. aureus in order to minimize 
resistance.
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